Tag: foghorn-therapeutics

Foghorn Therapeutics Plans a 40% Workforce Reduction After Ending a Lilly-Partnered Program

Foghorn Therapeutics plans to cut about 40% of its workforce, leaving about 65 full-time employees, after it and Eli Lilly decided not to advance FHD-909 into the expansion phase, according to an Oct. 1 SEC filing.